alexa
Reach Us +1-504-608-2390
Interview | Charles J MalemudnbspJournal of Clinical an
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Charles J Malemud
Charles J Malemud

Editor-in-Chief
Charles J. Malemud
Professor Medicine and Anatomy
Case Western Reserve University
USA
E-mail: [email protected]
Read Interview session with Charles J Malemud

 
Biography

Charles J Malemud is Associate Director of the Rheumatology Fellowship Training Program at University Hospitals Case Medical Center Professor of Medicine Anatomy Division of Rheumatic Diseases Case Western Reserve University School of Medicine Cleveland Ohio. He received the PhD in Experimental Pathology from the Department of Biology at George Washington University Washington DC 1969-1973. He completed his BS in Biology at Long Island University 1966. He was elected to Whomiddots Who in the World in 2007. He is serving as an editorial board member of 9 reputed journals and a peer-reviewer for numerous scientific journals. He has published a total of over 300 peer-reviewed papers abstracts and book chapters.

 
Research Interest

Biology of the Musculoskeletal System
Intracellular Signal Transduction Pathways
Inflammation
Pro-inflammatory, Anti-Inflammatory & Anabolic Cytokines
Apoptosis
Matrix Metalloproteinases
Osteoarthritis
Rheumatoid Arthritis
Fibromyalgia
Autoimmune Disorders

Interview

1. What is the research topic you are working on now?
The role that chondrocyte signal transduction plays in regulating matrix metalloproteinase gene expression and apoptosis in arthritis.

2. How many years have you been associated with the current research?
44 years.

3. What are the attributes for a quality article?
Conclusions are supported by data.

4. Do you have any research funding (NIH or other national funding) now?
Yes, PI: Genentech; Consultant/Collaborator: NICHD; Collaborator: NEI.

5. When did you become an editor of OMICS Journal?
2010-Member, Editorial Board, 2012-Editor-in-Chief.

6. Where can the journal find the maximum scope in terms of niche?
Basic research papers that connect fundamental studies in cellular immunology with a clinical problem (e.g. arthritis; multiple sclerosis; irritable bowel diseases including Crohn’s disease).

7. What is your greatest career accomplishment?
We discovered that chondrocytes produce matrix metalloproteinases (MMPs) which are the cause of cartilage destruction in arthritis (between 1980-1981 with continuing studies to date).

8. How does the published scientific content assist the potential researchers?
Provides a platform for establishing what background literature exists which enables researchers to move forward with a scientific study.

9. What is the purpose of serving as an editor?
Find suitable peer-reviewers; Make final decisions regarding suitability of peer-reviewed papers for publication.

10. Do you have any patents?
No.

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Yes.

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
IF REQUESTED.

13. How would you define your experience with OMICS Group?
Peer-review process is well-mamaged. Editorial decision making is straightforward. However, there has been a significant lag time from when invoices are submitted to my institution for payment of “page processing charges” and eventual payment to OMICS.

14. Your opinion on conducting Editorial Board meetings at related Conferences?
Each OMICS journal may have specific issues. Thus, each Editorial Board should meet separately.

15. Would you recommend OMICS to your friends or colleagues?
I continue to promote the JCCI to my colleagues. However, the fact that the JCCI papers are not automatically entered in the PubMed database has been an impediment.

16. How do you differentiate Journal of Clinical & Cellular Immunology with other journals in the field?
The JCCI has provided an opportunity for young investigators to receive a fair and impartial peer-review. I think this is one characteristic of the JCCI that distinguishes it from other society-based immunology journals.

Top